US FDA clears Glaxo pill for breast cancer
 Tuesday, March 13, 2007

US FDA clears Glaxo pill for breast cancer

Last Updated: 2007-03-13 16:08:06 -0400 (Reuters Health)

WASHINGTON (Reuters) - U.S. health regulators have approved GlaxoSmithKline Plc's pill Tykerb for patients with advanced breast cancer after other treatments have failed, a company spokeswoman said on Tuesday.

The drug was approved for once-daily use in combination with Roche Holding AG's oral chemotherapy drug Xeloda, or capecitabine, Glaxo spokeswoman Mary Anne Rhyne told Reuters.



Go Back 		 
Schwartzapfel Partners
With over 150 years of combined experience and highly competent co-counsel throughout the country, we can serve all your legal needs. Schwartzapfel Partners protects the rights of those who aren't able to do so themselves.    Learn More



Gender: Male Female
In what state did the incident occur?
Schwartzapfel Truhowsky Marcus
       Sachs P.C. disclaimer.

Clear